Literature DB >> 19455640

Methionine, tryptophan, and histidine oxidation in a model protein, PTH: mechanisms and stabilization.

Junyan A Ji1, Boyan Zhang, Wilson Cheng, Y John Wang.   

Abstract

Recent oxidation events on monoclonal antibody candidates prompted us to investigate the mechanism of oxidation of Met, Trp, and His residues and to search for suitable stabilizers. By using parathyroid hormone (1-34), PTH, as a model protein and various oxidants, aided by liquid chromatography, peptide mapping, and mass spectrometry, we identified and quantified the oxidation of these vulnerable residues. Whereas H(2)O(2) and t-butyl hydroperoxide (t-BHP) primarily oxidized the two Met residues, 2,2'-azobis(2-amidinopropane) dihydrochloride (AAPH), and H(2)O(2) + Fe(II) oxidized Met and Trp residues, with AAPH more capable of generating oxidized Trp species than the latter. H(2)O(2) + Fe(III) generated results comparable to those with H(2)O(2) + Fe(II), except that there was a lesser amount of hydroxylated Phe. Oxidation of the His residue in PTH occurred when copper was used instead of iron. AAPH, a free-radical generator, produced alkylperoxides, which simulated the oxidizing species from degraded polysorbate, commonly found in protein formulations. It is prudent to screen stabilizers by using H(2)O(2), H(2)O(2) + Fe(II), and AAPH because these agents represent potential assaults from the H(2)O(2) commonly present in degraded polysorbate, the residue of aseptic agents and the metal from stainless steel surfaces, and alkylperoxides from degraded polysorbate, respectively. Free Met protected the Met residues in PTH from oxidation by H(2)O(2) and H(2)O(2) + Fe(II). Mannitol and EDTA were effective against H(2)O(2) + Fe(II). Free Trp protected only the Trp residue in PTH from oxidation by AAPH, the combination of Trp and Met was effective against all three oxidant conditions. By using AAPH to generate oxidant, Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) and pyridoxine were also found to exhibit good free-radical scavenging activity and thus protected Trp in PTH against oxidation. 2009 Wiley-Liss, Inc. and the American Pharmacists Association

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19455640     DOI: 10.1002/jps.21746

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  41 in total

Review 1.  Oxidation of therapeutic proteins and peptides: structural and biological consequences.

Authors:  Riccardo Torosantucci; Christian Schöneich; Wim Jiskoot
Journal:  Pharm Res       Date:  2013-09-25       Impact factor: 4.200

2.  Complex Nature of Protein Carbonylation Specificity After Metal-Catalyzed Oxidation.

Authors:  Dmitry Kryndushkin; Wells W Wu; Ramesh Venna; Michael A Norcross; Rong-Fong Shen; V Ashutosh Rao
Journal:  Pharm Res       Date:  2017-02-01       Impact factor: 4.200

3.  Discovery and characterization of hydroxylysine in recombinant monoclonal antibodies.

Authors:  Qing Xie; Benjamin Moore; Richard L Beardsley
Journal:  MAbs       Date:  2015-12-14       Impact factor: 5.857

4.  Chemical modifications in therapeutic protein aggregates generated under different stress conditions.

Authors:  Quanzhou Luo; Marisa K Joubert; Riki Stevenson; Randal R Ketchem; Linda O Narhi; Jette Wypych
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

5.  In silico selection of therapeutic antibodies for development: viscosity, clearance, and chemical stability.

Authors:  Vikas K Sharma; Thomas W Patapoff; Bruce Kabakoff; Satyan Pai; Eric Hilario; Boyan Zhang; Charlene Li; Oleg Borisov; Robert F Kelley; Ilya Chorny; Joe Z Zhou; Ken A Dill; Trevor E Swartz
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-15       Impact factor: 11.205

6.  Development of a stable low-dose aglycosylated antibody formulation to minimize protein loss during intravenous administration.

Authors:  Sorina Morar-Mitrica; Manasi Puri; Alexandra Beumer Sassi; Joshua Fuller; Ping Hu; George Crotts; Douglas Nesta
Journal:  MAbs       Date:  2015       Impact factor: 5.857

7.  Unbiased in-depth characterization of CEX fractions from a stressed monoclonal antibody by mass spectrometry.

Authors:  François Griaud; Blandine Denefeld; Manuel Lang; Héloïse Hensinger; Peter Haberl; Matthias Berg
Journal:  MAbs       Date:  2017-04-05       Impact factor: 5.857

8.  An Efficient and Rapid Method to Monitor the Oxidative Degradation of Protein Pharmaceuticals: Probing Tyrosine Oxidation with Fluorogenic Derivatization.

Authors:  Rupesh Bommana; Olivier Mozziconacci; Y John Wang; Christian Schöneich
Journal:  Pharm Res       Date:  2017-04-18       Impact factor: 4.200

9.  Mitigation of Oxidation in Therapeutic Antibody Formulations: a Biochemical Efficacy and Safety Evaluation of N-Acetyl-Tryptophan and L-Methionine.

Authors:  Michelle Z Dion; Danielle Leiske; Vikas K Sharma; Christina L Zuch de Zafra; Cleo M Salisbury
Journal:  Pharm Res       Date:  2018-10-02       Impact factor: 4.200

10.  In vitro effect of H2O 2, some transition metals and hydroxyl radical produced via fenton and fenton-like reactions, on the catalytic activity of AChE and the hydrolysis of ACh.

Authors:  Armando Méndez-Garrido; Maricarmen Hernández-Rodríguez; Rafael Zamorano-Ulloa; José Correa-Basurto; Jessica Elena Mendieta-Wejebe; Daniel Ramírez-Rosales; Martha Cecilia Rosales-Hernández
Journal:  Neurochem Res       Date:  2014-08-06       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.